Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2019-04 Issue:4 Volume:25 Page:e128-e140
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Zeiser Robert,Beelen Dietrich W.^ORCID,Bethge Wolfgang,Bornhäuser Martin,Bug Gesine,Burchert Andreas,Christopeit Maximilian,Duyster Justus,Finke Jürgen^ORCID,Gerbitz Armin,Klusmann Jan Henning,Kobbe Guido,Lübbert Michael,Müller-Tidow Carsten,Platzbecker Uwe,Rösler Wolf,Sauer Martin,Schmid Christoph,Schroeder Thomas,Stelljes Mathias,Kröger Nicolaus,Müller Lutz P.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference138 articles.

1. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation;Heuser;Ann Hematol,2017

2. Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: a Center for International Blood and Marrow Transplant Research cohort analysis;Michelis;Cancer,2017

3. Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation;Della Porta;J Clin Oncol,2016

4. Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation;Schmid;Blood,2015

5. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation;Lindsley;N Eng J Med,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azacitidine combined with interferon‐α for pre‐emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study;British Journal of Haematology;2024-07-03

2. Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice;Journal of Clinical Investigation;2024-06-25

3. Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome–A propensity score matched analysis;Hematology, Transfusion and Cell Therapy;2024-05

4. Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia;British Journal of Haematology;2024-04-11

5. Metabolic instruction of the graft-versus-leukemia immunity;Frontiers in Immunology;2024-03-04